AI-ACCELERATED DRUG DISCOVERY

News

November 4, 2024

Receptor.AI Opens Headquarters in Boston, Strengthening U.S. Market Presence

October 28, 2024

Receptor.AI and Reaxense Inc. Present Innovative AI-Driven Focused On-Demand Libraries for Drug Discovery

October 7, 2024

Introducing ArtiDock 2.5: NEXT-GEN Molecular Docking

October 3, 2024

Presenting the LLM-driven Workflow Orchestrator

September 10, 2024

Receptor.AI and Moexa Announce Research Collaboration to Discover Novel Therapeutics Targeting Protein-Protein Interactions (PPIs) for Cancer and Fibrosis Treatment

June 11, 2024

Receptor.AI Marks Notable Presence at the ASCO and BIO International Convention 2024

March 19, 2024

Introducing ArtiDock 2.0: A New Era in AI-Driven Drug Discovery

March 13, 2024

Receptor.AI will attend Bio-Europe Spring Conference 2024

March 7, 2024

NVIDIA GTC Conference 2024 Presentation Announcement

December 1, 2023

Exciting News from the J.P. Morgan Healthcare Conference 2024

December 1, 2023

Receptor.AI Introduces ArtiDock

June 18, 2023

Receptor.AI Breaks New Ground with Revolutionary M3 Inhibitors

June 8, 2023

Unlocking the Potential of Cryptic Pockets with Receptor.AI

May 17, 2023

Advancing Drug Selectivity with Receptor.AI

April 14, 2023

Advancing Drug Discovery: Receptor.AI's AI-Augmented Structure-Based Prediction Methods

March 31, 2023

Receptor.AI Unveils Advanced ADME-Tox Prediction Model

March 17, 2023

Receptor.AI will attend Bio-Europe Spring Conference 2023